英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
misestimation查看　misestimation　在百度字典中的解释百度英翻中〔查看〕
misestimation查看　misestimation　在Google字典中的解释Google英翻中〔查看〕
misestimation查看　misestimation　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • YORVIPATH: First Hypoparathyroidism Treatment in Adults
    YORVIPATH is a prodrug of parathyroid hormone (PTH 1-34) administered once daily, designed to provide parathyroid hormone levels within the normal physiological range across the 24-hour dosing period YORVIPATH was granted marketing authorization by the European Commission (EC) in November 2023 as a PTH replacement therapy indicated for the treatment of adults with chronic hypoparathyroidism
  • Getting the Best Coverage for Your Psoriasis Treatment
    Jump To Coverage Navigation Help Manufacturer Assistance Coupon Find Support FSA and HSA Doctor’s Office With more treatment options than ever before for psoriasis (PsO), the odds are good that
  • Ascendis Pharma Reports Third Quarter 2025 Financial Results
    – Q3 2025 revenue of €143 1 million for YORVIPATH® and €50 7 million for SKYTROFA® – Q3 2025 operating profit of €11 0 million – TransCon® CNP (navepegritide) under FDA Priority
  • Yorvipath: Uses, Dosage, Side Effects, Warnings - Drugs. com
    Yorvipath (palopegteriparatide) is an injectable parathyroid hormone replacement therapy that can be used to treat adults with low parathyroid hormone levels (hypoparathyroidism) Yorvipath is self-administered subcutaneously (under the skin) using a pref
  • Approval [Rx ONLY] - Ascendis Pharma US
    YORVIPATH is a parathyroid hormone analog (PTH(1-34)) indicated for the treatment of hypoparathyroidism in adults (1)
  • PTH Replacement Therapies: Current Options and What’s Ahead
    Dr Tashko compares PTH therapies for hypoparathyroidism—Natpara, Forteo, YORVIPATH—and previews hopeful PTH replacements in clinical trials
  • Yorvipath (Palopegteriparatide Injection, for Subcutaneous . . .
    What Is Yorvipath? Yorvipath (palopegteriparatide) is a parathyroid hormone analog (PTH (1-34)) indicated for the treatment of hypoparathyroidism in adults What Are Side Effects of Yorvipath? Side effects of Yorvipath include: injection site reactions (bruising, redness, rash), vasodilatory signs and symptoms (dizziness, dizziness on standing, palpitations, fast heart rate, lightheadedness
  • Exploring How Nulibry, Yorvipath, And Ingrezza Work In . . .
    Medications like Nulibry, Yorvipath, and Ingrezza represent promising advances in this space, helping patients manage conditions previously lacking effective options In this guide, we'll explore how these three therapies work, who they may benefit, and what you should consider regarding treatment access and support resources





中文字典-英文字典  2005-2009